acetylcysteine has been researched along with alprostadil in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hansen, TW; Knisely, AS; Kocoshis, SA; Reyes, J; Rosh, J; Sigurdsson, L | 1 |
| Alonso, MH; Balistreri, WF; Bucuvalas, JC; Kotagal, U; Krug, S; Ryckman, FC | 1 |
| Akrishnan, VR; Menon, VP | 1 |
| Olthoff, KM | 1 |
| Morcos, SK | 1 |
| Adhikari, N; Burns, KE; Meade, MO | 2 |
| Itoh, Y; Oishi, R; Sendo, T; Yano, T | 1 |
| Bonewald, L; Brotto, M; Igwe, O; Mo, C; Vallejo, J; Wetmore, L; Zhao, R | 1 |
| Adeyi, OA; Barbas, AS; Echeverri, J; Goldaracena, N; Grant, DR; Kaths, JM; Louis, KS; Selzner, M; Selzner, N; Spetzler, VN | 1 |
4 review(s) available for acetylcysteine and alprostadil
| Article | Year |
|---|---|
Prevention of contrast media nephrotoxicity--the story so far.
Topics: Acetylcysteine; Alprostadil; Atrial Natriuretic Factor; Contrast Media; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Fenoldopam; Hemofiltration; Humans; Kidney Diseases; Renal Dialysis; Risk Factors; Vasodilator Agents | 2004 |
Pharmacologic therapies for adults with acute lung injury and acute respiratory distress syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alprostadil; Humans; Pulmonary Surfactants; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome | 2004 |
Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: systematic review and meta-analysis.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Alprostadil; Humans; Pentoxifylline; Randomized Controlled Trials as Topic; Respiration, Artificial; Respiratory Distress Syndrome; Surface-Active Agents; Vasodilator Agents | 2004 |
Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Topics: Acetylcysteine; Acute Kidney Injury; Adenosine; Alprostadil; Animals; Apoptosis; Ascorbic Acid; Atrial Natriuretic Factor; Contrast Media; Diuretics; Endothelins; Epoprostenol; Fenoldopam; Fluid Therapy; Hemodiafiltration; Hemofiltration; Humans; Iodine Radioisotopes; Kidney Tubules; Models, Biological; Renal Dialysis; Risk Factors | 2005 |
1 trial(s) available for acetylcysteine and alprostadil
| Article | Year |
|---|---|
Effect of treatment with prostaglandin E1 and N-acetylcysteine on pediatric liver transplant recipients: a single-center study.
Topics: Acetylcysteine; Alprostadil; Chi-Square Distribution; Drug Therapy, Combination; Free Radical Scavengers; Graft Rejection; Graft Survival; Humans; Liver Transplantation; Pilot Projects; Postoperative Complications; Statistics, Nonparametric; Treatment Outcome; Vasodilator Agents | 2001 |
7 other study(ies) available for acetylcysteine and alprostadil
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.
Topics: Acetylcysteine; Alprostadil; Antioxidants; Chelating Agents; Deferoxamine; Hemochromatosis; Humans; Infant, Newborn; Liver Transplantation; Retrospective Studies; Selenium; Treatment Outcome; Vitamin E | 1998 |
Potential role of antioxidants during ethanol-induced changes in the fatty acid composition and arachidonic acid metabolites in male Wistar rats.
Topics: Acetylcysteine; Alprostadil; Animals; Antioxidants; Arachidonic Acid; Body Weight; Brain; Central Nervous System Depressants; Curcumin; Dinoprost; Dinoprostone; Enzyme Inhibitors; Ethanol; Fatty Acids; Kidney; Liver; Male; Phospholipids; Prostaglandin D2; Rats; Rats, Wistar | 2001 |
Can reperfusion injury of the liver be prevented? Trying to improve on a good thing.
Topics: Acetylcysteine; Alprostadil; Child; Free Radical Scavengers; Humans; Liver Transplantation; Postoperative Complications; Reperfusion Injury; Vasodilator Agents | 2001 |
Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Topics: Acetylcysteine; Alprostadil; Animals; Cell Proliferation; Cells, Cultured; Dinoprostone; G1 Phase Cell Cycle Checkpoints; Immunohistochemistry; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Myoblasts; Reactive Oxygen Species; Receptors, Prostaglandin E, EP1 Subtype; Receptors, Prostaglandin E, EP2 Subtype; Receptors, Prostaglandin E, EP3 Subtype; Receptors, Prostaglandin E, EP4 Subtype; Signal Transduction; Thiophenes; Triazoles | 2015 |
Anti-inflammatory signaling during ex vivo liver perfusion improves the preservation of pig liver grafts before transplantation.
Topics: Acetylcysteine; Allografts; Alprostadil; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Biliary Tract; Bilirubin; Cold Ischemia; Cytokines; Endothelial Cells; Hyaluronic Acid; Inflammation Mediators; Liver; Liver Transplantation; Male; Methyl Ethers; Models, Animal; Organ Preservation; Perfusion; Reperfusion Injury; Sevoflurane; Sus scrofa; Swine; Temperature; Tissue and Organ Harvesting | 2016 |